Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00460603

Public ClinicalTrials.gov record NCT00460603. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 12:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase 2 Study Of The Anti-Angiogenesis Agent AG-013736 In Combinations With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer Preceded By A Phase 1 Portion

Study identification

NCT ID
NCT00460603
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

  • AG-013726 Drug
  • AG-013736 (axitinib) Drug
  • bevacizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Mar 31, 2012
Completion
Oct 31, 2012
Last update posted
Dec 5, 2013

2006 – 2012

United States locations

U.S. sites
106
U.S. states
23
U.S. cities
86
Facility City State ZIP Site status
Pfizer Investigational Site Daphne Alabama 36526
Pfizer Investigational Site Huntsville Alabama 35801
Pfizer Investigational Site Huntsville Alabama 35805
Pfizer Investigational Site Mobile Alabama 36608
Pfizer Investigational Site Antioch California 94531
Pfizer Investigational Site Colton California 92324
Pfizer Investigational Site Corona California 92879
Pfizer Investigational Site Gilroy California 95020
Pfizer Investigational Site Glendora California 91741
Pfizer Investigational Site La Jolla California 92037
Pfizer Investigational Site La Jolla California 92093
Pfizer Investigational Site Pasadena California 91105
Pfizer Investigational Site Pleasant Hill California 94523
Pfizer Investigational Site Pomona California 91767
Pfizer Investigational Site Rancho Cucamonga California 91730
Pfizer Investigational Site Rancho Mirage California 92270
Pfizer Investigational Site Redlands California 92374
Pfizer Investigational Site San Diego California 92103
Pfizer Investigational Site San Diego California 92121
Pfizer Investigational Site San Leandro California 94578
Pfizer Investigational Site West Covina California 91790
Pfizer Investigational Site Auroa Colorado 80012
Pfizer Investigational Site Boulder Colorado 80303
Pfizer Investigational Site Colorado Springs Colorado 80909
Pfizer Investigational Site Denver Colorado 80218
Pfizer Investigational Site Denver Colorado 80220
Pfizer Investigational Site Lakewood Colorado 80228
Pfizer Investigational Site Littleton Colorado 80120-4413
Pfizer Investigational Site Lone Tree Colorado 80124
Pfizer Investigational Site Longmont Colorado 80501
Pfizer Investigational Site Parker Colorado 80138
Pfizer Investigational Site Thornton Colorado 80260
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Stuart Florida 34994
Pfizer Investigational Site Atlanta Georgia 30318
Pfizer Investigational Site Beech Grove Indiana 46107
Pfizer Investigational Site Indianapolis Indiana 46237
Pfizer Investigational Site Jeffersonville Indiana 47130
Pfizer Investigational Site Muncie Indiana 47303
Pfizer Investigational Site Kansas City Kansas 66112
Pfizer Investigational Site Overland Park Kansas 66210
Pfizer Investigational Site Louisville Kentucky 40202
Pfizer Investigational Site Louisville Kentucky 40207
Pfizer Investigational Site Louisville Kentucky 40217
Pfizer Investigational Site Louisville Kentucky 40241
Pfizer Investigational Site Shelbyville Kentucky 40065
Pfizer Investigational Site Baton Rouge Louisiana 70809
Pfizer Investigational Site Brownstone Michigan 48183
Pfizer Investigational Site Dearborn Michigan 48126
Pfizer Investigational Site Detroit Michigan 48202
Pfizer Investigational Site West Bloomfield Michigan 48322
Pfizer Investigational Site Kansas City Missouri 64111
Pfizer Investigational Site Kansas City Missouri 64131
Pfizer Investigational Site Kansas City Missouri 64154
Pfizer Investigational Site Lee's Summit Missouri 64064
Pfizer Investigational Site St Louis Missouri 63110
Pfizer Investigational Site Grand Island Nebraska 68803
Pfizer Investigational Site Las Vegas Nevada 89135
Pfizer Investigational Site Summit New Jersey 07902
Pfizer Investigational Site Albany New York 12206
Pfizer Investigational Site Albany New York 12208
Pfizer Investigational Site Amsterdam New York 12010
Pfizer Investigational Site Hudson New York 12534
Pfizer Investigational Site Latham New York 12110-0610
Pfizer Investigational Site Rexford New York 12148
Pfizer Investigational Site Troy New York 12180
Pfizer Investigational Site Kernersville North Carolina 27284
Pfizer Investigational Site Lexington North Carolina 27295
Pfizer Investigational Site Mount Airy North Carolina 27030
Pfizer Investigational Site North Wilkesboro North Carolina 28659
Pfizer Investigational Site Pollocksville North Carolina 28573
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Oregon City Oregon 97045
Pfizer Investigational Site Portland Oregon 97213
Pfizer Investigational Site Portland Oregon 97225
Pfizer Investigational Site Portland Oregon 97227
Pfizer Investigational Site Tualatin Oregon 97062
Pfizer Investigational Site West Reading Pennsylvania 19611
Pfizer Investigational Site Charleston South Carolina 29406
Pfizer Investigational Site Easley South Carolina 29640
Pfizer Investigational Site Greenville South Carolina 29605
Pfizer Investigational Site Greenville South Carolina 29615
Pfizer Investigational Site Seneca South Carolina 29672
Pfizer Investigational Site Spartanburg South Carolina 29307
Pfizer Investigational Site Chattanooga Tennessee 37403
Pfizer Investigational Site Franklin Tennessee 37067
Pfizer Investigational Site Gallatin Tennessee 37066
Pfizer Investigational Site Hermitage Tennessee 37076
Pfizer Investigational Site Lebanon Tennessee 37087
Pfizer Investigational Site Nashville Tennessee 37203
Pfizer Investigational Site Nashville Tennessee 37205
Pfizer Investigational Site Nashville Tennessee 37207
Pfizer Investigational Site Nashville Tennessee 37211
Pfizer Investigational Site Smyrna Tennessee 37167
Pfizer Investigational Site Dallas Texas 75235
Pfizer Investigational Site Dallas Texas 75237
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site Dallas Texas 75390
Pfizer Investigational Site Fort Worth Texas 76177
Pfizer Investigational Site Houston Texas 77090
Pfizer Investigational Site Tyler Texas 75702
Pfizer Investigational Site Ogden Utah 84403-3274
Pfizer Investigational Site Everett Washington 98201
Pfizer Investigational Site Kennewick Washington 99336
Pfizer Investigational Site Vancouver Washington 98684
Pfizer Investigational Site Vancouver Washington 98686

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00460603, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2013 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00460603 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →